SCHEMBL30860765

SCHEMBL30860765

CS(=O)(=O)Nc1cc2c(cc1N)OCO2

nearest known ligand 0.45

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
PTGS1 P23219 1/20 0.44
PTGS2 P35354 1/20 0.44
PIK3CD O00329 1/20 0.44
RAB9A P51151 1/20 0.43
GLO1 Q04760 1/20 0.41
KMT2A Q03164 4/20 0.41
MEN1 O00255 3/20 0.41
MAPT P10636 2/20 0.41
POLB P06746 2/20 0.41
MCL1 Q07820 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
HPGD P15428 2/20 0.40
KIF11 P52732 1/20 0.39
PKM P14618 1/20 0.39
ALDH1A1 P00352 3/20 0.37
LMNA P02545 2/20 0.37
KDM4E B2RXH2 1/20 0.36
TDP1 Q9NUW8 1/20 0.36
KLK7 P49862 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30860738 0.78 FABP4 (0.40) PIK3CDRAB9AKMT2AMEN1MAPT
SCHEMBL26906693 0.78 FABP4 (0.40) PTGS2RAB9AKMT2AMEN1MAPT
SCHEMBL13090795 0.76 MEN1 (0.43) RAB9AKMT2AMEN1MAPTPOLB
SCHEMBL30860742 0.74 MAPT (0.51) PTGS1PTGS2PIK3CDKMT2AMEN1
SCHEMBL6970062 0.73 KMT2A (0.39) PTGS1PTGS2RAB9AKMT2AMEN1
SCHEMBL7339922 0.73 KMT2A (0.39) PTGS1PTGS2RAB9AKMT2AMEN1
SCHEMBL21363749 0.73 CYP3A4 (0.43) PTGS1PTGS2PIK3CDRAB9AGLO1
SCHEMBL12017944 0.70 MAPT (0.71) RAB9AKMT2AMEN1MAPTPOLB
SCHEMBL546296 0.70 MAPT (0.56) KMT2AMEN1MAPTPOLBMCL1
SCHEMBL29415600 0.70 MAPT (0.56) KMT2AMEN1MAPTPOLBMCL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024072075-A1 PYRIMIDINE DERIVATIVE HAVING PROTEIN KINASE INHIBITORY ACTIVITY, AND THERAPEUTIC PHARMACEUTICAL COMPOSITION COMPRISING SAME 주식회사 테라펙스 2024-04-04 WO disclosed